Success Stories: EB-1A Approved for a Postdoctoral Scientist in Minnesota in the Field of Pharmaceutics
Client’s Testimonial:
Thank you for everything. I would say 100% credit goes to you for this.
We Received EB1-A (Alien of Extraordinary Ability) Approval on October 23rd, 2014 for a Postdoctoral Scientist inMinnesota in the Field of Pharmaceutics (Approval Notice)
Position at the Time of Case Filing: Postdoctoral Scientist
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Minnesota
Approval Notice Date: October 23rd, 2014
Processing Time: 23 Days (7 Days after upgrading to Premium Processing)
In this case, the client that we had the pleasure of working with was a Postdoctoral Scientist from India in the field of Pharmaceutics. His specialized research has focused on designing and evaluating drug delivery systems for diseases such as colon cancer. His work had resulted in at least 9 peer-reviewed scientific articles, 1 book chapter and numerous presentations at national and international conferences. At the time that his case was filed, his publications had been cited at least 88 times by researchers around the world, serving as apparent and objective evidence of his major influence and impact on the field of endeavor, in addition to his sustained international acclaim. He had also conducted 35 manuscript reviews for at least 5 distinctive, internationally circulated journals. His superior level of expertise was confirmed in the following quote from a recommender, “Drug delivery specialists such as myself (and client) focus specifically on ways to make existing drugs (or drugs currently in development) better able to treat human patients in a way that reduces side effects and increases effectiveness. This is highly important to the health of patients all across the globe and to the pharmaceutical industry in particular, as it is quite possible they could spend money developing a product which cannot be used in humans without modification. [Client] has done some very important and novel work in this area. Not only has his work resulted in specific improvements to several drugs, but it has also directly provided our field with better methods of analyzing drugs and designing experiments.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Pharmaceutics, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in just 23 days.